caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1003967845

Rebecca PerretM.D.

Obstetrics & GynecologyNew Orleans, LAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 190036
Hospital
CCN 190039
Hospital
CCN 190046
Hospital
CCN 190176
Hospital
REFERRAL NETWORK

Where Rebecca Perret's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
TOURO INFIRMARY30147
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
1347
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
63
Unique beneficiaries
—
Total services
64
Distinct HCPCS
1
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 383 Obstetrics & Gynecology providers in LA — below median (cohort median 103).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$349
Payment records
20
By payment type
Food and Beverage$349
PRESCRIBING · PART D · 2024
Total Rx claims
159
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
6
Brand share
35.2%
Top prescribed drugs
Estradiol56 claims
Valacyclovir Hcl26 claims
Progesterone, Micronized19 claims
Clobetasol Propionate18 claims
Medroxyprogesterone Acetate18 claims
QUALITY · MIPS · 2024
Final MIPS score
76.3
Quality
71.6
Cost
72.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.05%
Group